MIRUM

Mirum Pharmaceuticals is a pioneering pharmaceutical company that focuses on developing treatments for rare genetic disorders, such as Alagille syndrome, through groundbreaking research and development efforts. Their dedication to providing effective solutions for patients with cholestatic pruritus showcases their commitment to improving the quality of life for individuals and families affected by these conditions.

We use cookies to enhance your experience. By continuing to visit this site, you agree to our cookies policy